Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema

European Journal of Ophthalmology

Volumn 14, Issue 6, 2004, Pages 543-549

  Ozkiris A ^a,c   Evereklioglu, C ^a   Erkilic K ^a   Tamcelik N ^b   Mirza, E ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Kayseri 38030 Turkey   (Turkey)

Author keywords

Diabetic macular edema; Intravitreal triamcinolone; Primary treatment

Indexed keywords

ANTIGLAUCOMA AGENT; CIPROFLOXACIN; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DRUG EFFICACY; DRUG INDICATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OPHTHALMOSCOPY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETINA ANGIOGRAPHY; RETINA MACULA EDEMA; STATISTICAL SIGNIFICANCE; VISUAL ACUITY;

EID: 12344329847     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210401400615     Document Type: Article

References (33)

1. Pelzek C, Lim JI. Diabetic macular edema: review and update. Ophthalmol Clin North Am 2002; 15: 555-63.
2. Cunha-Vaz J. Diabetic macular edema. Eur J Ophthalmol 1998; 8: 127-30.
3. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1998; 105: 998-1003.
4. Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994; 101: 1061-70.
5. Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 1999; 14: 223-32.
6. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 2003; 26: 2653-64.
7. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology 1987; 94: 761-74.
8. Otani T, Kishi S. A controlled study of vitrectomy for diabetic macular edema. Am J Ophthalmol 2002; 134: 214-29.
9. Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 2001; 132: 369-77.
10. Aiello LP. The potential role of PKC beta in diabetic retinopathy and macular edema. Surv Ophthalmol 2002; 47: S263-9.
11. Kivilcim M, Peyman GA, El-Dessouky ES, Kazi AA, Cheema R, Hegazy H. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg Lasers 2000; 31: 474-8.
12. McCuen BW, Bessler M, Tano Y, Chandler D, Machemer R. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981; 91: 785-8.
13. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E Jr. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110: 1155-9.
14. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 2003; 136: 384-6.
15. Gillies MC, Simpson JM, Luo W, et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol 2003; 121: 667-73.
16. Ozkiris A, Evereklioglu C, Erkilic K, Göktas S. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion. Eur J Ophthalmol 2005 (in press).
17. Ozkiris A, Evereklioglu C, Erkilic K, Dogan H. Intravitreal triamcinolone acetonide for treatment of persistent macular edema in branch retinal vein occlusion. Eye 2005 (in press).
18. Ozkiris A, Evereklioglu C, Erkilic K. Intravitreal triamcinolone acetonide injection for the treatment of posterior segment uveitis. Ocul Immunol Inflamm 2005 (in press).
19. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002; 86: 247-8.
20. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132: 425-7.
21. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109: 920-7.
22. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 121: 57-61.
23. Holladay JT. Proper method for calculating average visual acuity. J Refr Surg 1997; 13: 388-91.
24. Zambarakji HJ, Evans JE, Amoaku WM, Vernon SA. Reproducibility of volumetric measurements of normal maculae with the Heidelberg retina tomograph. Br J Ophthalmol 1998; 82: 884-91.
25. Lewis H, Schachat AP, Haimann MH, et al. Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology 1990; 97: 503-10.
26. Ozerdem U, Freeman WR. Exudative retinal detachment following grid laser photocoagulation in a patient with hemiretinal vein occlusion. Eur J Ophthalmol 2001; 11: 89-92.
27. Han DP, Mieler WF, Burton TC. Submacular fibrosis after photocoagulation for diabetic macular edema. Am J Ophthalmol 1992; 113: 513-21.
28. Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 1993; 45: 3-7.
29. Kosaka T. The effects of prostaglandins on the blood-retinal barrier. Nippon Ganka Gakkai Zasshi 1995; 99: 412-9.
30. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 2001; 29: 2-6.
31. Sutter FK, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol 2003; 87: 972-4.
32. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003; 23: 686-91.
33. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003; 121: 1279-82.